The Importance of Targeted Drug Delivery Systems on Pancreatic Cancer

References (121)

1. 1 TOR, a Central Controller of Cell Growth [DOI]
2. 2 Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer [DOI]
3. 3 A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [DOI]
4. 4 Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma [DOI]
5. 5 Solid lipid nanoparticles: A modern formulation approach in drug delivery system [DOI]
6. 6 Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.
7. 7 Mutation of the PIK3CA oncogene in human cancers [DOI]
8. 8 p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.
9. 9 Germline and Somatic Mutations of the STK11/LKB1 Peutz-Jeghers Gene in Pancreatic and Biliary Cancers [DOI]
10. 10 High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma [DOI]
11. 11 HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas [DOI]
12. 12 Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging [DOI]
13. 13 Multi-functional polymeric nanoparticles for tumour-targeted drug delivery [DOI]
14. 14 The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems [DOI]
15. 15 The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
16. 16 Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas [DOI]
17. 17 The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells [DOI]
18. 18 Incidence, mechanism and prognostic value of activated AKT in pancreas cancer [DOI]
19. 19 BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer [DOI]
20. 20 Potential Tumor Suppressive Pathway Involving DUSP6/MKP-3 in Pancreatic Cancer [DOI]
21. 21 3,3′-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5 [DOI]
22. 22 Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines [DOI]
23. 23 Cerium oxide nanoparticles: potential applications for cancer and other diseases.
24. 24 Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence [DOI]
25. 25 Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery [DOI]
26. 26 O-Carboxymethyl chitosan nanoparticles for metformin delivery to pancreatic cancer cells [DOI]
27. 27 Pancreatic Cancer [DOI]
28. 28 Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.
29. 29 Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
30. 30 ACVR1B ( ALK4 , activin receptor type 1B) gene mutations in pancreatic carcinoma [DOI]
31. 31 Radiofrequency field‐induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles [DOI]
32. 32 Missense Mutations of MADH4 [DOI]
33. 33 KLF4 is a Novel Candidate Tumor Suppressor Gene in Pancreatic Ductal Carcinoma [DOI]
34. 34 Multifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancer [DOI]
35. 35 SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling [DOI]
36. 36 Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan [DOI]
37. 37 Transcriptional Network Governing the Angiogenic Switch in Human Pancreatic Cancer [DOI]
38. 38 Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside [DOI]
39. 39 Inhibition of Amyloid Precursor Protein Processing Enhances Gemcitabine-mediated Cytotoxicity in Pancreatic Cancer Cells [DOI]
40. 40 Kinase signaling pathways as targets for intervention in pancreatic cancer [DOI]
41. 41 K- RAS Mutation in the Screening, Prognosis and Treatment of Cancer [DOI]
42. 42 p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma.
43. 43 K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
44. 44 siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
45. 45 Apoptosis of pancreatic cancer BXPC-3 cells induced by indole-3-acetic acid in combination with horseradish peroxidase [DOI]
46. 46 RETRACTED: Knockdown of Snail Sensitizes Pancreatic Cancer Cells to Chemotherapeutic Agents and Irradiation [DOI]
47. 47 Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis [DOI]
48. 48 Development of gene therapy to target pancreatic cancer [DOI]
49. 49 Chemotherapy in pancreatic cancer [DOI]
50. 50 Pancreatic Cancer: Current Concepts in Invasion and Metastasis [DOI]
51. 51 Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses [DOI]
52. 52 Vascular endothelial growth factor (VEGF) and its receptors [DOI]
53. 53 Solid lipid nanoparticles Production, characterization and applications [DOI]
54. 54 Therapeutic Nanoparticles for Drug Delivery in Cancer [DOI]
55. 55 DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 [DOI]
56. 56 Nanoparticle and targeted systems for cancer therapy [DOI]
57. 57 DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer [DOI]
58. 58 Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy [DOI]
59. 59 The Regulation of INK4/ARF in Cancer and Aging [DOI]
60. 60 The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications [DOI]
61. 61 The Two TORCs and Akt [DOI]
62. 62 The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells [DOI]
63. 63 Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer [DOI]
64. 64 Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis [DOI]
65. 65 Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma [DOI]
66. 66 miR-146a Suppresses Invasion of Pancreatic Cancer Cells [DOI]
67. 67 Hypermethylation of multiple genes in pancreatic adenocarcinoma.
68. 68 SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells [DOI]
69. 69 Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production [DOI]
70. 70 The Pathology and Genetics of Metastatic Pancreatic Cancer [DOI]
71. 71 Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
72. 72 STK11/LKB1 Peutz-Jeghers Gene Inactivation in Intraductal Papillary-Mucinous Neoplasms of the Pancreas [DOI]
73. 73 Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy [DOI]
74. 74 Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer [DOI]
75. 75 Transcriptional network governing the angiogenic switch in human pancreatic cancer [DOI]
76. 76 Liposome based delivery systems in pancreatic cancer treatment: From bench to bedside [DOI]
77. 77 Imaging Pancreatic Cancer with a Peptide−Nanoparticle Conjugate Targeted to Normal Pancreas [DOI]
78. 78 miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4 [DOI]
79. 79 Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c [DOI]
80. 80 Epidermal Growth Factor Receptor Expression in Pancreatic Carcinoma Using Tissue Microarray Technique [DOI]
81. 81 Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1 [DOI]
82. 82 HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells [DOI]
83. 83 Parthenolide induces proliferation inhibition and apoptosis of pancreatic cancer cells in vitro [DOI]
84. 84 Mucin 16 is a functional selectin ligand on pancreatic cancer cells [DOI]
85. 85 Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family [DOI]
86. 86 Mechanistic studies of Gemcitabine-loaded nanoplatforms in resistant pancreatic cancer cells [DOI]
87. 87 Antitumor Effects of Rapamycin in Pancreatic Cancer Cells by Inducing Apoptosis and Autophagy [DOI]
88. 88 Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation [DOI]
89. 89 G 1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: Phenotypes reversed by a tumorigenic mutation [DOI]
90. 90 Membrane proteomic analysis of pancreatic cancer cells [DOI]
91. 91 Induction of Apoptosis in Tumor-Associated Endothelial Cells and Therapy of Orthotopic Human Pancreatic Carcinoma in Nude Mice [DOI]
92. 92 Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer [DOI]
93. 93 Induction of Apoptosis and Autophagy in Human Pancreatic Cancer Cells by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin [DOI]
94. 94 Early Effects of Lasonolide A on Pancreatic Cancer Cells [DOI]
95. 95 αVintegrin: A new gastrin target in human pancreatic cancer cells [DOI]
96. 96 Chemotherapy for pancreatic cancer [DOI]
97. 97 Novel therapies for pancreatic adenocarcinoma [DOI]
98. 98 RASSF2 Induces Activated Ras-Dependent Cell Growth Inhibition and Apoptosis in Human Pancreatic Cancer Cells
99. 99 Induction of Apoptosis and Anoikis by Bit1 in Pancreatic Cancer Cells [DOI]
100. 100 Genetics and biology of pancreatic ductal adenocarcinoma [DOI]
101. 101 Mutations of the BRAF gene in human cancer [DOI]
102. 102 EGFR Antagonists in Cancer Treatment [DOI]
103. 103 Recent progress in pancreatic cancer [DOI]
104. 104 The Prevalence of BRCA2 Mutations in Familial Pancreatic Cancer [DOI]
105. 105 Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatment [DOI]
106. 106 Targeting of NAD Metabolism in Pancreatic Cancer Cells: Potential Novel Therapy for Pancreatic Tumors [DOI]
107. 107 Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis [DOI]
108. 108 RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy [DOI]
109. 109 Treatment of Pancreatic Cancer Cells with Dicumarol Induces Cytotoxicity and Oxidative Stress [DOI]
110. 110 Design of Nanoparticles as Drug Carriers for Cancer Therapy.
111. 111 EGFR Antagonists in Cancer Treatment [DOI]
112. 112 Resveratrol induces apoptosis in pancreatic cancer cells.
113. 113 Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
114. 114 Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines [DOI]
115. 115 Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src [DOI]
116. 116 Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest [DOI]
117. 117 Novel therapies for pancreatic adenocarcinoma [DOI]
118. 118 Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells [DOI]
119. 119 Suppression of human pancreatic cancer cell proliferation by AGN194204, an RXR-selective retinoid [DOI]
120. 120 Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and Caveolin-1 [DOI]
121. 121 Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis [DOI]

Cited by 0

No indexed citations yet.

Related research

• Application of Peptide-Conjugated Photosensitizers for Photodynamic Cancer Therapy: A Review — shares topic coverage
• Mulberry (Morus spp.): A Comprehensive Review of Its Medicinal and Functional Properties — shares topic coverage
• An Elderly Postmenopausal Hormone Receptor Negative Breast Cancer Survivor Lady with a Giant Serous Cyst Adenoma of Ovary: A Case Report — shares topic coverage
• Decoding Tumor Drug Resistance: Present Status and Future Landscapes — shares topic coverage
• Molecular Crosstalk between Cancer Stem Cells and the Tumor Microenvironment: Therapeutic Implications — shares topic coverage